In-Vitro Diagnostics Market to 2027 - Global Analysis and Forecasts By Product and Services (Reagents and Kits, Instruments, and Software and Services); Technology (Immunoassay/Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Urinalysis, and Others); Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, and Others); End User (Hospitals, Diagnostic Centers, Homecare, and Others), and Geography
- THE3479229
- 261 Pages
- January 2020
- Diagnostic and Biotech
The growth of the In-Vitro Diagnostics market is primarily attributed to the factors such as increasing prevalence of chronic diseases, rising geriatric population and rising awareness of in-vitro diagnostics across the globe. However, factors such as lack of healthcare infrastructure in emerging nations and poor reimbursement policies likely to pose a negative impact on the market growth. On the other hand, growth opportunities in emerging regions are likely to have a positive impact on the growth of the global In-Vitro Diagnostics market during the forecast period. With a rise in cases of chronic illnesses such as diabetes, cancer, and inflammatory diseases, the healthcare domain is witnessing increasing emphasis on preventive care and rapid disease diagnosis. Such factors are likely to boost the preference for in-vitro diagnostics in developed as well as developing nations. Moreover, increasing geriatric population coupled with increasing demand for advanced systems to incorporate accurate disease diagnosis is projected to offer lucrative opportunity for the growth of the global in-vitro diagnostics market. Asia Pacific is anticipated to offer significant growth opportunity during the forecast period, due to an increase in the disposable income as well as developing healthcare infrastructure in the leading economies such as Japan, China and India.
Chronic diseases, such as diabetes, cancer, and obesity, are the leading causes of death in the world and account for most of the nation’s health care costs. According to report of CDC, in 2018, approximately more than 9% of the population has diabetes, which is the leading cause of kidney failure, lower-limb amputations in US. Moreover, the data also suggests that 1.5 million Americans are diagnosed with diabetes every year in the US. Similar trends for high presence of diabetes are prevalent around other geographies of the globe that include Asia Pacific, Europe, Middle East and Africa. For instance, according to IDF Diabetes Atlas published by the International Diabetes Federation in 2017, south-east Asia is home to approximately one-fifth (19%) of the total diabetes population worldwide.
In 2019, the In-Vitro Diagnostics with reagents and kits held a largest market share of 80.18% of the In-Vitro Diagnostics market, by product & services. Infectious diseases in application segment is also expected to dominate the market in 2027 owing to higher prevalence of infectious diseases and increasing number of viral outbreaks.
Global In-Vitro Diagnostics devices market, based on the Product and Services, is segmented into Reagents and Kits, Instruments, and Software & Service. In 2019, the reagents & kits segment held the largest share of the market, by products & services. In addition, the segment is also expected to grow at the fastest rate during the coming years owing to increasing number diagnostics test across the globe.
Global In-Vitro Diagnostics devices market, based on the technology, is segmented into Immunoassay/Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Urinalysis, and Others. In 2019, the Immunoassay/Immunochemistry segment held the largest share of the market, by technology. In addition, the segment is also expected to grow at the fastest rate during the coming years owing to increasing adoption of the technology due to its benefits for the diagnosis of infectious diseases.
Global In-Vitro Diagnostics devices market, based on the applications, is segmented into Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, and Others. In 2019, the Infectious Diseases segment held the largest share of the market, applications. In addition, the segment is also expected to grow at the fastest rate during the coming years.
Global In-Vitro Diagnostics devices market, based on the end user was segmented into Hospitals, Diagnostic Centers, Homecare, and Others. In 2019, the hospitals segment held the largest share of the market, by end user, owing to well-established and presence of advanced healthcare infrastructure, growing concerns about health and rising healthcare spending. Whereas, the homecare segment is expected to grow at the fastest rate during the coming years.
Some of the major primary and secondary sources for In-Vitro Diagnostics included in the report are Centers for Disease Control and Prevention (CDC), USFDA, Biotelemetry and Patient Monitoring Journal, Journal of Patient Care, China Food & Drug Administration, contract research organizations, and among others.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global In Vitro Diagnostics Market – By Product and Services
1.3.2 Global In Vitro Diagnostics Market – By Technology
1.3.3 Global In Vitro Diagnostics Market – By Application
1.3.4 Global In Vitro Diagnostics Market – By End User
1.3.5 Global In Vitro Diagnostics Market – By Geography
2. In Vitro Diagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. In Vitro Diagnostics– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 In Vitro Diagnostics Market in North America: PEST Analysis
4.2.2 In Vitro Diagnostics Market in Europe: PEST Analysis
4.2.3 In Vitro Diagnostics Market in Middle East & Africa: PEST Analysis
4.2.4 In Vitro Diagnostics Market in South and Central America: PEST Analysis
4.3 Expert Opinion
5. In Vitro Diagnostics Market – Key Dynamics
5.1 Key Market Drivers
5.1.1 Increasing prevalence of chronic and infectious diseases
5.1.2 Growing Geriatric Population
5.2 Key Market Restraints
5.2.1 Lack of Healthcare Infrastructure and Reimbursement Policies
5.3 Key Market Opportunity
5.3.1 Emerging Markets in Emerging Nations
5.4 Future Trend
5.4.1 Increasing Adoption and Popularity of Automation in Clinical Laboratories
5.5 Impact Analysis
6. In Vitro Diagnostics Market – Global Analysis
6.1 Global In Vitro Diagnostics Market Revenue Forecast And Analysis
6.2 Global In Vitro Diagnostics Market, By Geography - Forecast And Analysis
6.3 Positioning of Key Players
6.3.1 F. Hoffmann-La Roche Ltd
6.3.2 Abbott
7. In Vitro Diagnostics Market Analysis and Forecasts to 2027 – Product & Service
7.1 Overview
7.2 Global In-Vitro Diagnostics, by Product, 2018 & 2027 (% Share)
7.3 Instruments
7.3.1 Overview
7.4 Reagents & Kits
7.4.1 Overview
7.4.2 Global Equipment Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Software & Services
7.5.1 Overview
7.5.2 Global Media and Reagent Market Revenue and Forecast to 2027 (US$ Mn)
8. In Vitro Diagnostics Market Analysis and Forecasts to 2027 – Application
8.1 Overview
8.2 Global In Vitro Diagnostics Market, by Application, 2018 & 2027 (% Share)
8.3 Infectious Diseases
8.3.1 Overview
8.3.2 Global Infectious Diseases Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Diabetes
8.4.1 Overview
8.4.2 Global Diabetes Market Revenue and Forecast to 2027 (US$ Mn)
8.5 Oncology
8.5.1 Overview
8.5.2 Global Oncology Market Revenue and Forecast to 2027 (US$ Mn)
8.6 Cardiology
8.6.1 Overview
8.6.2 Global Cardiology Market Revenue and Forecast to 2027 (US$ Mn)
8.7 Nephrology
8.7.1 Overview
8.7.2 Global Nephrology Market Revenue and Forecast to 2027 (US$ Mn)
8.8 Others
8.8.1 Overview
8.8.2 Global Others Market Revenue and Forecast to 2027 (US$ Mn)
9. In Vitro Diagnostics Market Analysis and Forecasts to 2027 – Technology
9.1 Overview
9.2 Global In Vitro Diagnostics Market, by Technology, 2018 & 2027 (% Share)
9.3 Immunoassay/Immunochemistry
9.3.1 Overview
9.3.2 Global Immunoassay/Immunochemistry Market Revenue and Forecast to 2027 (US$ Mn)
9.4 Clinical Chemistry
9.4.1 Overview
9.4.2 Global Clinical Chemistry Market Revenue and Forecast to 2027 (US$ Mn)
9.5 Molecular Diagnostics
9.5.1 Overview
9.5.2 Global Molecular Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)
9.6 Hematology
9.6.1 Overview
9.7 Urinalysis
9.7.1 Overview
9.7.2 Global Urinalysis Market Revenue and Forecast to 2027 (US$ Mn)
9.8 Others
9.8.1 Overview
9.8.2 Global Others Market Revenue and Forecast to 2027 (US$ Mn)
10. In Vitro Diagnostics Market Analysis And Forecasts To 2027 – End User
10.1 Overview
10.2 Global In Vitro Diagnostics Market Share by End User 2018 & 2027 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Global Hospitals Market Revenue and Forecast to 2027 (US$ Mn)
10.4 Diagnostic Centres
10.4.1 Overview
10.4.2 Global Diagnostic Centers Market Revenue and Forecast to 2027 (US$ Mn)
10.5 Homecare
10.5.1 Overview
10.5.2 Global Homecare Market Revenue and Forecast to 2027 (US$ Mn)
10.6 Others
10.6.1 Overview
10.6.2 Global Others Market Revenue and Forecasts to 2027 (US$ Mn)
11. In Vitro Diagnostics Market Analysis And Forecasts To 2027 – Geographical Analysis
11.1 North America In Vitro Diagnostics Market Revenue And Forecasts To 2027
11.1.1 North America In Vitro Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.2 North America In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.1.3 North America In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.1.4 North America In Vitro Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.1.5 North America In Vitro Diagnostics Market Revenue and Forecasts to 2027, By Country (%)
11.1.6 US
11.1.6.1 US In Vitro Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.6.2 US In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.1.6.3 US In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.1.6.4 US In Vitro Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.1.7 Canada
11.1.7.1 Canada In Vitro Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.7.2 Canada In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.1.7.3 Canada In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.1.7.4 Canada In Vitro Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.1.8 Mexico
11.1.8.1 Mexico In Vitro Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.8.2 Mexico In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.1.8.3 Mexico In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.1.8.4 Mexico In Vitro Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2 Europe In Vitro Diagnostics Market Revenue and Forecasts to 2027
11.2.1 Europe In Vitro Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.2 Europe In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)
11.2.3 Europe In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.2.4 Europe In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.2.5 Europe In Vitro Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.6 Europe In Vitro Diagnostics Market Revenue and Forecasts to 2027, By Country (%)
11.2.7 Germany
11.2.7.1 Germany In Vitro Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.7.2 Germany In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)
11.2.7.3 Germany In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.2.7.4 Germany In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.2.7.5 Germany In Vitro Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.8 UK
11.2.8.2 UK In Vitro Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.8.3 UK In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)
11.2.8.4 UK In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.2.8.5 UK In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.2.8.6 UK In Vitro Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.9 France
11.2.9.1 France In Vitro Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.9.2 France In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)
11.2.9.3 France In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.2.9.4 France In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.2.9.5 France In Vitro Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.10 Spain
11.2.10.1 Spain In Vitro Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.10.2 Spain In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)
11.2.10.3 Spain In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.2.10.4 Spain In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.2.10.5 Spain In Vitro Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.11 Italy
11.2.11.1 Italy In Vitro Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.11.2 Italy In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)
11.2.11.3 Italy In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.2.11.4 Italy In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.2.11.5 Italy In Vitro Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.3 Asia Pacific In Vitro Diagnostics Market Revenue and Forecast to 2027
11.3.1 Overview
11.3.2 Asia Pacific In Vitro Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.3 Asia Pacific In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)
11.3.4 Asia Pacific In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.3.5 Asia Pacific In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.3.6 Asia Pacific In Vitro Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.3.7 Asia Pacific In Vitro Diagnostics Market Revenue and Forecast to 2027, By Country (%)
11.3.8 China
11.3.8.1 China In Vitro Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.8.2 China In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)
11.3.8.3 China In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.3.8.4 China In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.3.8.5 China In Vitro Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.3.9 Japan
11.3.9.1 Japan In Vitro Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.9.2 Japan In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)
11.3.9.3 Japan In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.3.9.4 Japan In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.3.9.5 Japan In Vitro Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.3.10 India
11.3.10.1 India In Vitro Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.10.2 India In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)
11.3.10.3 India In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.3.10.4 India In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.3.10.5 India In Vitro Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.3.11 South Korea
11.3.11.1 South Korea In Vitro Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.11.2 South Korea In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)
11.3.11.3 South Korea In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.3.11.4 South Korea In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.3.11.5 South Korea In Vitro Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.3.12 Australia
11.3.12.1 Australia In Vitro Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.12.2 Australia In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)
11.3.12.3 Australia In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.3.12.4 Australia In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.3.12.5 Australia In Vitro Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.4 Middle East and Africa In Vitro Diagnostics Market Revenue And Forecasts To 2027
11.4.1 Middle East and Africa In Vitro Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.2 Middle East and Africa In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.4.3 Middle East and Africa In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.4.4 Middle East and Africa In Vitro Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.4.5 Middle East and Africa In Vitro Diagnostics Market Revenue and Forecasts to 2027, By Country (%)
11.4.6 UAE
11.4.6.1 UAE In Vitro Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.6.2 UAE In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.4.6.3 UAE In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.4.6.4 UAE In Vitro Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.4.7 Saudi Arabia
11.4.7.1 Saudi Arabia In Vitro Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.7.2 Saudi Arabia In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.4.7.3 Saudi Arabia In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.4.7.4 Saudi Arabia In Vitro Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.4.8 South Africa
11.4.8.1 South Africa In Vitro Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.8.2 South Africa In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.4.8.3 South Africa In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.4.8.4 South Africa In Vitro Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.5 South and Central America In Vitro Diagnostics Market Revenue And Forecasts To 2027
11.5.1 South and Central America In Vitro Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.2 South and Central America In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.5.3 South and Central America In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.5.4 South and Central America In Vitro Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.5.5 South and Central America In Vitro Diagnostics Market Revenue and Forecasts to 2027, By Country (%)
11.5.6 Argentina
11.5.6.1 Argentina In Vitro Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.6.2 Argentina In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.5.6.3 Argentina In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.5.6.4 Argentina In Vitro Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.5.7 Brazil
11.5.7.1 Brazil In Vitro Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.7.2 Brazil In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.5.7.3 Brazil In Vitro Diagnostics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.5.7.4 Brazil In Vitro Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
12. Global In Vitro Diagnostics Market – Industry Landscape
12.1 Overview
12.2 Growth Strategies Done By the Companies in The Market, (%)
12.3 Organic Developments Done By The Companies in The Market
12.4 Inorganic Developments Done By The Companies in The Market
13. Global In Vitro Diagnostics Market–Key Company Profiles
13.1 Abbott
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 F. HOFFMANN-LA ROCHE LTD
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Danaher
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Siemens AG
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Sysmex Corporation
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 THERMO FISHER SCIENTIFIC INC.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 BD
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 bioMerieux SA
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 BIO-RAD LABORATORIES INC.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.11. QIAGEN
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
Similar Reports
Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...
- Publish Date: September 1, 2016
- $5370
The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...
- Publish Date: May 24, 2017
- $5370
Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early dia...
- Publish Date: May 24, 2017
- $5370
